IDENTIFICATION OF MUTATIONS IN THE CODING SEQUENCE OF THE PROTOONCOGENE C-KIT IN A HUMAN MAST-CELL LEUKEMIA-CELL LINE CAUSING LIGAND-INDEPENDENT ACTIVATION OF C-KIT PRODUCT
被引:706
|
作者:
FURITSU, T
论文数: 0引用数: 0
h-index: 0
机构:OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
FURITSU, T
TSUJIMURA, T
论文数: 0引用数: 0
h-index: 0
机构:OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
TSUJIMURA, T
TONO, T
论文数: 0引用数: 0
h-index: 0
机构:OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
TONO, T
IKEDA, H
论文数: 0引用数: 0
h-index: 0
机构:OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
IKEDA, H
KITAYAMA, H
论文数: 0引用数: 0
h-index: 0
机构:OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
KITAYAMA, H
KOSHIMIZU, U
论文数: 0引用数: 0
h-index: 0
机构:OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
KOSHIMIZU, U
SUGAHARA, H
论文数: 0引用数: 0
h-index: 0
机构:OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
SUGAHARA, H
BUTTERFIELD, JH
论文数: 0引用数: 0
h-index: 0
机构:OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
BUTTERFIELD, JH
ASHMAN, LK
论文数: 0引用数: 0
h-index: 0
机构:OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
ASHMAN, LK
KANAYAMA, Y
论文数: 0引用数: 0
h-index: 0
机构:OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
KANAYAMA, Y
MATSUZAWA, Y
论文数: 0引用数: 0
h-index: 0
机构:OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
MATSUZAWA, Y
KITAMURA, Y
论文数: 0引用数: 0
h-index: 0
机构:OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
KITAMURA, Y
KANAKURA, Y
论文数: 0引用数: 0
h-index: 0
机构:OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
KANAKURA, Y
机构:
[1] OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,2-2 YAMADA OKA,SUITA,OSAKA 565,JAPAN
PROTOONCOGENE C-KIT;
POINT MUTATION;
LEUKEMIA;
TYROSINE KINASE;
ACTIVATION;
D O I:
10.1172/JCI116761
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
The c-kit proto-oncogene encodes a receptor tyrosine kinase. Binding of c-kit ligand, stem cell factor (SCF) to c-kit receptor (c-kitR) is known to activate c-kitR tyrosine kinase, thereby leading to autophosphorylation of c-kitR on tyrosine and to association of c-kitR with substrates such as phosphatidylinositol 3-kinase (PI3K). In a human mast cell leukemia cell line HMC-1, c-kitR was found to be constitutively phosphorylated on tyrosine, activated, and associated with PI3K without the addition of SCF. The expression of SCF mRNA transcript in HMC-1 cells was not detectable by means of PCR after reverse transcription (RT-PCR) analysis, suggesting that the constitutive activation of c-kitR was ligand independent. Sequencing of whole coding region of c-kit cDNA revealed that c-kit genes of HMC-1 cells were composed of a normal, wild-type allele and a mutant allele with two point mutations resulting in intracellular amino acid substitutions of Gly-560 for Val and Val-816 for Asp. Amino acid sequences in the regions of the two mutations are completely conserved in all of mouse, rat, and human c-kit. In order to determine the causal role of these mutations in the constitutive activation, murine c-kit mutants encoding Gly-559 and/or Val-814, corresponding to human Gly-560 and/or Val-816, were constructed by site-directed mutagenesis and expressed in a human embryonic kidney cell line, 293T cells. In the transfected cells, both c-kitR (Gly-559, Val-814) and c-kitR (Val-814) were abundantly phosphorylated on tyrosine and activated in immune complex kinase reaction in the absence of SCF, whereas tyrosine phosphorylation and activation of c-kitR (Gly-559) or wild-type c-kitR was modest or little, respectively. These results suggest that conversion of Asp-816 to Val in human c-kitR may be an activating mutation and responsible for the constitutive activation of c-kitR in HMC-1 cells.